Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lillicrap

Showing results (91-100 of 216) with videos related to

Pageof 22
Sort By:
Blood|December 7, 2006
Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearanceMaha Othman, Andrea Labelle, Ian Mazzetti, et al.
Thrombosis Research|November 25, 2010
Functional analysis of three recombinant A1-VWF domain mutants in comparison to wild type and plasma-derived VWF facilitates subtyping in type 2 von Willebrand diseaseRouzbeh Chegeni, Linda Vickars, Emmanuel J Favaloro, et al.
Journal of Visualized Experiments : Jove|August 23, 2017
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String FormationAlison Michels, Laura L Swystun, Jeffrey Mewburn, et al.
Journal of Thrombosis and Haemostasis : JTH|February 20, 2020
The highly prevalent deletions in F8 intron 13 found in French mild hemophilia A patients result from both founder effect and recurrent de novo eventsYohann Jourdy, Mathilde Frétigny, Fanny Lassalle, et al.
Journal of Pediatric Hematology/Oncology|December 24, 2010
Early intraoperative blood collection does not affect complete blood counts, von Willebrand factor or factor VIII levels in normal childrenHanni Darwish, Gillianne Mundell, Dale Engen, et al.
Thrombosis and Haemostasis|March 28, 2002
Recombinant factor IX recovery and inhibitor safety: a Canadian post-licensure surveillance studyMan-Chiu Poon, David Lillicrap, Caroline Hensman, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|June 30, 2010
Characterization of viability and proliferation of alginate-poly-L-lysine-alginate encapsulated myoblasts using flow cytometryAjit Thakur, Ruchira Sengupta, Hideto Matsui, et al.
Human Gene Therapy|September 14, 2002
The canine factor VIII 3'-untranslated region and a concatemeric hepatocyte nuclear factor 1 regulatory element enhance factor VIII transgene expression in vivoColleen Notley, Annie Killoran, Cherie Cameron, et al.
Blood Advances|June 20, 2020
Gut dysbiosis modulates the immune response to factor VIII in murine hemophilia AJulie Tarrant, Matthew Cormier, Kate Nesbitt, et al.
Pediatric Blood & Cancer|March 23, 2011
Therapeutic consequences for misdiagnosis of type 2N von Willebrand diseaseMadhu Gupta, David Lillicrap, Ann Marie Stain, et al.
Pageof 22

Showing results (91-100 of 216) with videos related to

Sort By:
Pageof 22
Blood|December 7, 2006
Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearanceMaha Othman, Andrea Labelle, Ian Mazzetti, et al.
Thrombosis Research|November 25, 2010
Functional analysis of three recombinant A1-VWF domain mutants in comparison to wild type and plasma-derived VWF facilitates subtyping in type 2 von Willebrand diseaseRouzbeh Chegeni, Linda Vickars, Emmanuel J Favaloro, et al.
Journal of Visualized Experiments : Jove|August 23, 2017
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String FormationAlison Michels, Laura L Swystun, Jeffrey Mewburn, et al.
Journal of Thrombosis and Haemostasis : JTH|February 20, 2020
The highly prevalent deletions in F8 intron 13 found in French mild hemophilia A patients result from both founder effect and recurrent de novo eventsYohann Jourdy, Mathilde Frétigny, Fanny Lassalle, et al.
Journal of Pediatric Hematology/Oncology|December 24, 2010
Early intraoperative blood collection does not affect complete blood counts, von Willebrand factor or factor VIII levels in normal childrenHanni Darwish, Gillianne Mundell, Dale Engen, et al.
Thrombosis and Haemostasis|March 28, 2002
Recombinant factor IX recovery and inhibitor safety: a Canadian post-licensure surveillance studyMan-Chiu Poon, David Lillicrap, Caroline Hensman, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|June 30, 2010
Characterization of viability and proliferation of alginate-poly-L-lysine-alginate encapsulated myoblasts using flow cytometryAjit Thakur, Ruchira Sengupta, Hideto Matsui, et al.
Human Gene Therapy|September 14, 2002
The canine factor VIII 3'-untranslated region and a concatemeric hepatocyte nuclear factor 1 regulatory element enhance factor VIII transgene expression in vivoColleen Notley, Annie Killoran, Cherie Cameron, et al.
Blood Advances|June 20, 2020
Gut dysbiosis modulates the immune response to factor VIII in murine hemophilia AJulie Tarrant, Matthew Cormier, Kate Nesbitt, et al.
Pediatric Blood & Cancer|March 23, 2011
Therapeutic consequences for misdiagnosis of type 2N von Willebrand diseaseMadhu Gupta, David Lillicrap, Ann Marie Stain, et al.
Pageof 22